STIM · Neuronetics, Inc. · Webcasts, Transcripts & Audio
$1.39
-0.04 (-2.80%)
At close · Nov 13
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Going-concern doubt
— flagged Nov 4, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Therefore, substantial doubt exists about the Company’s ability to continue as a going concern. However, at this time, these actions do not fully mitigate the risk related to compliance with the revenue covenant for the March 31, 2027 period.”View the 10-Q filed Nov 4, 2026
Market Cap
$108.04M
Shares
77.73M
Volume · Nov 13
16.26M
Avg daily vol (3M)
1.64M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Neuronetics, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Neuronetics, Inc. (STIM), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-04
Neuronetics, Inc. (STIM) Q3 2026 Earnings Call
Revenue
$41.96M
▲ 12.5% YoY Diluted EPS
$-0.02
Gross margin
52.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-08-11
Neuronetics, Inc. (STIM) Q2 2026 Earnings Call
Positive tone
Greenbrook clinic operational performance
Neurostar commercial model evolution
Path to profitability and cash generation
Revenue
$41.57M
▲ 9.1% YoY Diluted EPS
$-0.05
Gross margin
51.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-05
Neuronetics, Inc. (STIM) Q1 2026 Earnings Call Transcript
Balanced tone
NeuroStar capital system sales
SPRAVATO and buy-and-bill growth
TMS volumes and weather impact
Revenue
$34.45M
▲ 7.8% YoY Diluted EPS
$-0.16
Gross margin
46.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-17
Neuronetics, Inc. (STIM) Q4 2025 Earnings Call Transcript
Confident tone
Greenbrook integration and clinic growth
Neurostar capital systems
Spravato rollout and optimization
Revenue
$41.78M*
▲ 85.7% YoY Gross margin
52.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Neuronetics, Inc. (STIM) Q3 2025 Earnings Call Transcript
Positive tone
SPRAVATO rollout and billing mix
Revenue guidance
Greenbrook clinic growth and integration
Revenue
$37.30M
▲ 101.3% YoY Diluted EPS
$-0.13
Gross margin
45.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript
Positive tone
Greenbrook integration and clinic performance
SPRAVATO rollout and buy-and-bill model
Better Me Provider (BMP) program
Revenue
$38.11M
▲ 131.7% YoY Diluted EPS
$-0.15
Gross margin
46.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Neuronetics, Inc. (STIM) Q1 2025 Earnings Call Transcript
Confident tone
Greenbrook integration
SPRAVATO rollout
BMP / Better Me Provider program
Revenue
$31.98M
▲ 83.6% YoY Diluted EPS
$-0.21
Gross margin
49.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-04
Neuronetics, Inc. (STIM) Q4 2024 Earnings Call
Revenue
$22.49M*
▲ 10.7% YoY Gross margin
66.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript
Balanced tone
Greenbrook acquisition and integration
SPRAVATO expansion and buy-and-bill
Q4 revenue guidance shortfall
Revenue
$18.53M
▲ 3.6% YoY Diluted EPS
$-0.44
Gross margin
75.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-12
Neuronetics, Inc. (STIM) Q2 2024 Earnings Call Transcript
Positive tone
Greenbrook TMS Merger and Synergies
Site Utilization and Revenue per Site
Adolescent FDA Clearance and Insurance Coverage
Revenue
$16.45M
▼ 6.6% YoY Diluted EPS
$-0.33
Gross margin
74.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Neuronetics, Inc. (STIM) Q1 2024 Earnings Call Transcript
Positive tone
Better Me Guarantee Provider Program
Capital system shipments
Change Healthcare cybersecurity incident impact
Revenue
$17.42M
▲ 12.1% YoY Diluted EPS
$-0.27
Gross margin
75.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-05
Neuronetics, Inc. (STIM) Q4 2023 Earnings Call Transcript
Positive tone
Better Me Guarantee Provider Program
Treatment Session Revenue Growth
Greenbrook Relationship
Revenue
$20.31M*
▲ 11.6% YoY Gross margin
77.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Neuronetics, Inc. (STIM) Q3 2023 Earnings Call Transcript
Revenue
$17.88M
▲ 8.4% YoY Diluted EPS
$-0.33
Gross margin
65.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Neuronetics, Inc. (STIM) Q2 2023 Earnings Call Transcript
Revenue
$17.61M
▲ 7.8% YoY Diluted EPS
$-0.17
Gross margin
72.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Neuronetics, Inc. (STIM) Q1 2023 Earnings Call Transcript
Revenue
$15.54M
▲ 9.6% YoY Diluted EPS
$-0.38
Gross margin
73.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-09
Neuronetics, Inc. (STIM) Q4 2022 Earnings Call Transcript
Revenue
$18.20M*
▲ 21.1% YoY Gross margin
75.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Neuronetics, Inc. (STIM) Q3 2022 Earnings Call Transcript
Revenue
$16.50M
▲ 19.6% YoY Diluted EPS
$-0.28
Gross margin
78.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Neuronetics, Inc. (STIM) Q2 2022 Earnings Call Transcript
Revenue
$16.33M
▲ 15% YoY Diluted EPS
$-0.39
Gross margin
75.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Neuronetics, Inc. (STIM) Q1 2022 Earnings Call Transcript
Revenue
$14.18M
▲ 15.4% YoY Diluted EPS
$-0.41
Gross margin
75.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-08
Neuronetics, Inc. (STIM) Q4 2021 Earnings Call Transcript
Revenue
$15.02M*
▼ 3.6% YoY Gross margin
76.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-12
Neuronetics, Inc. (STIM) Q3 2021 Earnings Call Transcript
Revenue
$13.80M
▲ 10.9% YoY Diluted EPS
$-0.31
Gross margin
77.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Neuronetics, Inc. (STIM) Q2 2021 Earnings Call Transcript
Revenue
$14.20M
▲ 45.8% YoY Diluted EPS
$-0.29
Gross margin
80.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Neuronetics, Inc. (STIM) Q1 2021 Earnings Call Transcript
Revenue
$12.29M
▲ 7.1% YoY Diluted EPS
$-0.31
Gross margin
81.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-13
Neuronetics, Inc. (STIM) Q4 2020 Earnings Call Transcript
Revenue
$15.58M
▼ 10.2% YoY Gross margin
75.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-02
Neuronetics, Inc. (STIM) Q3 2020 Earnings Call Transcript
Revenue
$12.45M
▼ 22.2% YoY Diluted EPS
$-0.18
Gross margin
78.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
Neuronetics, Inc. (STIM) Q2 2020 Earnings Call Transcript
Revenue
$9.74M
▼ 41.2% YoY Diluted EPS
$-0.41
Gross margin
76.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Neuronetics, Inc. (STIM) Q1 2020 Earnings Call Transcript
Revenue
$11.48M
▼ 9.8% YoY Gross margin
75.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-03
Neuronetics, Inc. (STIM) Q4 2019 Earnings Call
Revenue
$17.36M
▲ 11% YoY Gross margin
75.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 webcasts